Literature DB >> 7716704

The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.

D A Horwitz1, C O Jacob.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7716704     DOI： 10.1007/bf00197516

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  145 in total

1.  Generation and characterization of cloned T helper cell lines for anti-DNA responses in NZB.H-2bm12 mice.

Authors:  M Naiki; B L Chiang; D Cawley; A Ansari; S J Rozzo; B L Kotzin; A Zlotnik; M E Gershwin
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

2.  Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  G Semenzato; L M Bambara; D Biasi; A Frigo; F Vinante; B Zuppini; L Trentin; C Feruglio; M Chilosi; G Pizzolo
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

3.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

4.  Genetic analysis of the imperfect association of H-2 haplotype with lupus-like autoimmune disease.

Authors:  S K Babcock; V B Appel; M Schiff; E Palmer; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Saito; F Shirakawa; T Ota; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

6.  Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation.

Authors:  D H Campen; D A Horwitz; F P Quismorio; G R Ehresmann; W J Martin
Journal:  Arthritis Rheum       Date:  1988-11

7.  Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.

Authors:  B J Nelson; P Ralph; S J Green; C A Nacy
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

8.  Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2.

Authors:  A M Malygin; S Meri; T Timonen
Journal:  Scand J Immunol       Date:  1993-01       Impact factor: 3.487

9.  The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus.

Authors:  R C Jandl; J L George; D S Silberstein; R B Eaton; P H Schur
Journal:  Clin Immunol Immunopathol       Date:  1987-03

10.  Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression.

Authors:  Y Tanaka; K Saito; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422
View more
  16 in total

Review 1.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

2.  Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.

Authors:  A Shustov; I Luzina; P Nguyen; J C Papadimitriou; B Handwerger; K B Elkon; C S Via
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus.

Authors:  E Eilat; M Dayan; H Zinger; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  Drug combination therapy of systemic lupus erythematosus.

Authors:  P A Miescher; H Favre; R Lemoine; Y P Huang
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis.

Authors:  Y Nishitani; A Kubo; M Iwano; N Minamino; K Hamano; T Fujimoto; T Nishino; H Shiiki; K Yonemasu; K Dohi
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

6.  Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.

Authors:  Alaa Sabry; Sherief Refat Elbasyouni; Hussein A Sheashaa; Amr A Alhusseini; Khaled Mahmoud; Shahir Kamal George; Ehab Abdel Kaleek; Hamdy abo-Zena; Abdalla M Kalil; Tareek Mohsen; Mona Abdel Rahim; Ayman Z El-samanody
Journal:  Int Urol Nephrol       Date:  2007-01-27       Impact factor: 2.370

7.  Intrarenal cytokine gene expression in lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Fernand Mac-Moune Lai; Edmund Kwok-Ming Li; Lai-Shan Tam; Kai-Ming Chow; Ka-Bik Lai; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

Review 8.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

9.  T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice.

Authors:  M G Papamattheou; J G Routsias; E E Karagouni; C Sakarellos; M Sakarellos-Daitsiotis; H M Moutsopoulos; A G Tzioufas; E N Dotsika
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

10.  A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide.

Authors:  Amir Sharabi; Molly Dayan; Heidy Zinger; Edna Mozes
Journal:  J Clin Immunol       Date:  2009-09-16       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.